Verona Pharma

Verona Pharma develops novel treatments like ensifentrine in COPD. Future development is focused on chronic lung diseases such as COPD, asthma, and cystic fibrosis. Explore our advancements, patient insights, and latest investor news

New Enterprise Associates

🏥 Healthcare